Canada markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
56.02-6.67 (-10.64%)
At close: 04:00PM EDT
56.06 +0.04 (+0.07%)
After hours: 06:35PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.63B
Enterprise Value 3.83B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)100.37
Price/Book (mrq)5.26
Enterprise Value/Revenue 84.38
Enterprise Value/EBITDA -9.87

Trading Information

Stock Price History

Beta (5Y Monthly) 2.02
52-Week Change 3-48.07%
S&P500 52-Week Change 3-14.73%
52 Week High 3143.92
52 Week Low 337.08
50-Day Moving Average 361.33
200-Day Moving Average 367.93

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 31.1M
Shares Outstanding 576.01M
Implied Shares Outstanding 6N/A
Float 868.85M
% Held by Insiders 19.72%
% Held by Institutions 188.18%
Shares Short (Sept 14, 2022) 46.68M
Short Ratio (Sept 14, 2022) 46.68
Short % of Float (Sept 14, 2022) 410.10%
Short % of Shares Outstanding (Sept 14, 2022) 48.79%
Shares Short (prior month Aug 14, 2022) 46.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-849.04%

Management Effectiveness

Return on Assets (ttm)-26.99%
Return on Equity (ttm)-58.23%

Income Statement

Revenue (ttm)45.34M
Revenue Per Share (ttm)0.61
Quarterly Revenue Growth (yoy)114.20%
Gross Profit (ttm)-186.75M
EBITDA -377.7M
Net Income Avi to Common (ttm)-400.43M
Diluted EPS (ttm)-5.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)874.28M
Total Cash Per Share (mrq)11.5
Total Debt (mrq)69.56M
Total Debt/Equity (mrq)7.90
Current Ratio (mrq)7.24
Book Value Per Share (mrq)11.59

Cash Flow Statement

Operating Cash Flow (ttm)-284.56M
Levered Free Cash Flow (ttm)-172.59M